Potentials and Limitations of Bile Acids in Type 2 Diabetes Mellitus: Applications of Microencapsulation as a Novel Oral Delivery System

QR Code

Potentials and Limitations of Bile Acids in Type 2 Diabetes Mellitus: Applications of Microencapsulation as a Novel Oral Delivery System

Type 2 diabetes (T2D) is a chronic metabolic disorder resulting from genetic and environmental factors that bring about tissue desensitization to insulin and consequent hyperglycemia. Despite strict glycemic control and the fact that new and more effective antidiabetic drugs are continuously appeari...

Full description

Bibliographic Details
Main Authors:	Negrulj, Rebecca, Mooranian, Armin, Al-Salami, Hani
Format:	Journal Article
Published:	Synergy Publishers 2013
Subjects:	inflammation type 2 diabetes bile acids Microencapsulation
Online Access:	http://hdl.handle.net/20.500.11937/25888

Similar Items

Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics
by: Mooranian, Armin, et al.
Published: (2014)

Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: A Characterization Study
by: Mooranian, Armin, et al.
Published: (2014)

An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer
by: Mooranian, Armin, et al.
Published: (2014)

Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 Diabetes
by: Mooranian, Armin, et al.
Published: (2014)

Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol
by: Mooranian, Armin, et al.
Published: (2014)

Cutting-edge biotechnological advancement in islet delivery using pancreatic and cellular approaches.
by: Elnashar, Magdy, et al.
Published: (2020)

Gliclazide reduces MKC intestinal transport in healthy but not diabetic rats
by: Al-Salami, Hani, et al.
Published: (2009)

Application of bile acids in drug formulation and delivery
by: Stojancevic, M., et al.
Published: (2014)

Novel artificial cell microencapsulation of probucol and bile acids in diabetes mellitus
by: Mooranian, Armin
Published: (2018)

Investigating the bile acid mediated control of Clostridioides difficile infection
by: von Emloh, Louise
Published: (2024)

The impact of allylamine-bile acid combinations on cell delivery microcapsules in diabetes
by: Mooranian, Armin, et al.
Published: (2016)

Characterization of a novel bile acid-based delivery platform for microencapsulated pancreatic ß-cells.
by: Mooranian, Armin, et al.
Published: (2014)

Microencapsulation of Betacyanin extract from amaranth
by: Chong, Pik Han
Published: (2015)

Viability and topographical analysis of microencapsulated ß-cells exposed to a biotransformed tertiary bile acid: An ex vivo study
by: Mooranian, Armin, et al.
Published: (2016)

Microencapsulation of Bifidobacterium pseudocatenulatum G4 using natural matrices
by: Abdul Khalil, Khalilah
Published: (2012)

The relationship between urinary albumin excretion, cardiovascular outcomes and total mortality among a large cohort of insulin-treated patients with type 2 diabetes in routine primary care practices
by: Anyanwagu, Uchenna Chidi, et al.
Published: (2018)

Species Classification and Molecular Studies of Bile Salt Hydrolase (BSH) Gene in Bifidobacterium Spp
by: Mustafa, Shuhaimi
Published: (2003)

An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques
by: Mooranian, Armin, et al.
Published: (2019)

Data supporting development and validation of liquid chromatography tandem mass spectrometry method for the quantitative determination of bile acids in feces
by: Shafaei, A., et al.
Published: (2021)

An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations
by: Mooranian, A., et al.
Published: (2015)

Microencapsulated Nigella sativa L. oil as functional ingredient for non-dairy creamer
by: Mohammed, Nameer Khairullah
Published: (2018)

Quantitative analysis of male foetal DNA in maternal circulation in gestational diabetes mellitus, iron deficiency anaemia and hypertensive pregnancies
by: Zamanpoor, Mansour
Published: (2009)

Sedentary time and markers of inflammation in people with newly diagnosed type 2 diabetes
by: Falconer, C.L., et al.
Published: (2014)

The roles of bile acids and applications of microencapsulation technology in treating Type 1 diabetes mellitus
by: Woodhams, L., et al.
Published: (2017)

Analysis of g s-transferase, protien tyrosine phosphatase 1B, nuclear factor kappa-B1 and leptin receptor genetic polymorphisms as risk factors for Malaysian type 2 diabetes mellitus subjects
by: Etemad, Ali
Published: (2013)

Extraction and quantitative determination of bile acids in feces
by: Shafaei, A., et al.
Published: (2021)

Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment
by: Mooranian, Armin, et al.
Published: (2015)

Factors associated with glycaemic control among diabetes mellitus type 2 patients attending health clinics in Tampin district Negeri Sembilan, Malaysia
by: Wan Hamdzan, Wan Farzana Fasya
Published: (2016)

Effect of microencapsulation efficiency of maltodextrin produced from breadfruit and broken rice and its in vitro wound healing efficacy
by: Mohamed Amin, Zahiah
Published: (2015)

Preparation of microencapsulated phase change materials (MEPCM) for thermal energy storage
by: Su, Weiguang, et al.
Published: (2017)

The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study
by: Mooranian, A., et al.
Published: (2015)

Association of dietary patterns with socio-demographic, lifestyle, weight status and biochemical profiles among type 2 diabetes mellitus patients in a special Medical Center, Tehran Iran
by: Zad, Nasrin Darani
Published: (2012)

Effectiveness of simplified diabetes nutrition education on glycemic control, and other diabetes-related outcomes in patients with type 2 diabetes mellitus in Basrah, Iraq
by: Hashim, Almaliki Saman Agad
Published: (2020)

Flow vibration-doubled concentric system coupled with low ratio amine to produce bile acid-macrocapsules of ß-cells
by: Mooranian, Armin, et al.
Published: (2016)

Metabolic effects of Cosmos caudatus Kunth (ulam raja) supplementation in type-2 diabetes mellitus patients
by: Cheng, Shi Hui
Published: (2017)

Factors of medication non-adherence among type 2 diabetes mellitus patients in Malaysian public hospitals
by: Abdullah, Nor Fadhilah
Published: (2020)

Properties of alginate-chitosan microcapsule containing tocotrienols in self-assembled pickering emulsion and its stability in yogurt
by: Tan, Phui Yee
Published: (2017)

Effects of Antioxidant Vitamin C, E and C+E Supplementation on Plasma Lipid Profiles, Glycemic Control, and Antioxidant Status Among Type 2 Diabetes Mellitus Subjects in Tehran, Iran
by: Rafighi, Zahra
Published: (2011)

Advanced bile acid-based multi-compartmental microencapsulated pancreatic ß-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment.
by: Mooranian, A., et al.
Published: (2014)

The incorporation of water-soluble gel matrix into bile acid-based microcapsules for the delivery of viable ß-cells of the pancreas, in diabetes treatment: biocompatibility and functionality studies.
by: Mooranian, A., et al.
Published: (2015)